Recro Pharma
REPH
#8553
Rank
A$0.18 B
Marketcap
$3.20
Share price
-0.48%
Change (1 day)
-30.18%
Change (1 year)

Earnings for Recro Pharma (REPH)

Earnings in 2021 (TTM): A$5.13 Million

According to Recro Pharma 's latest financial reports the company's current earnings are A$75.36 Million. In 2020 the company made an earning of -A$12.74 Million a decrease over its 2019 earnings that were of A$37.44 Million.

Earnings history for Recro Pharma from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)A$5.13 M-140.28%
2020-A$12.74 Million-134.02%
2019A$37.44 M-145.64%
2018-A$82.05 Million34.08%
2017-A$61.19 Million55.21%
2016-A$39.43 Million258.83%
2015-A$10.99 Million-39.6%
2014-A$18.19 Million989.11%
2013-A$1.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$28.19 B 488,608.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.13 Billion-2,209.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.15 B 2,571.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$15.77 Million-373.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.17 Billion-2,882.65%๐Ÿ‡บ๐Ÿ‡ธ USA